News J&J seeks to rewrite the script on depression treatment A survey has found that most patients with depression have little hope of being free of their symptoms, and Johnson & Johnson aims to change that.
News AI-powered study finds multiple Parkinson’s types Researchers have used a machine learning algorithm to try to work out why Parkinson's disease patients can respond so differently to treatment.
News NICE backs UCB drug as first uncontrolled gMG therapy UCB's Rystiggo can be used by the NHS as a backup treatment for people with the rare autoimmune and neuromuscular disease gMG, says NICE.
News UK study finds clue to rising cancer rates in younger people A study has found evidence that 11 cancers are becoming more common among young people in England, and points to a main driving factor.
News Can Purdue finally get its bankruptcy plan over the line? OxyContin manufacturer Purdue is on the brink of a bankruptcy deal that could put years of opioid liability litigation in its rearview mirror.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
News Remepy's hybrid Parkinson's therapy poised for phase 3 Remepy's Hybridopa therapy for Parkinson's, which combines an app with levodopa therapy, has shown efficacy in a phase 2 pilot study.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.